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Abstract
BACKGROUND: 18F-FDG PET/CT has become an important tool in diagnosis of prosthetic vascular graft infections (PVGI). 
The aim of the study was to identify the patterns of vascular graft infection in 18F-FDG PET/CT.
MATERIAL AND METHODS: The study was performed in 24 patients with vascular graft infection, in 17 patients implanted 
in an open surgery mode and in 7 patients by endovascular aortic repair (EVAR). Vascular prostheses were evaluated by two 
visual scales and semi-quantitative analysis with maximum standardized uptake values (SUV max). 
RESULTS: In the 3-point scale: 23 patients were in grade 1 and one patient was in grade 2. In the 5-point scale: 19 patients were 
in grade 5 with the highest activity in the focal area, 4 patients were in grade 4 and one patient in grade 3. The visual evaluation 
of 18F-FDG PET/CT study revealed that peri-graft high metabolic activity was associated with occurrence of morphological 
abnormalities (n = 21) like gas bubbles and peri-graft fluid retention or without abnormal CT findings (n = 3). The presence 
of the gas bubbles was linked to higher uptake of 18F-FDG (p < 0.01, SUVmax 11.81 ± 4.35 vs 7.36 ± 2.80, 15 vs 9 pts). In 
EVAR procedure, the highest metabolic activity was greater than in classical prosthesis (SUVmax 21.5 vs 13). 
CONCLUSIONS: 18F-FDG PET/CT is a very useful tool for assessment of vascular graft infections. CT findings like gas bub-
bles, or peri-graft fluid retention were associated with significantly higher glucose metabolism; however, in some cases without 
anatomic alterations, increased metabolic activity was the only sign of infection.
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Introduction
The incidence of prosthetic vascular graft infections (PVGI) 
is ranging between 1 and 6%, depending on the location of the 
vascular graft — in intra-abdominal prostheses, the overall risk of 
infections is around 1%, but considerably increases to 6% when 
the graft is anastomosed to a femoral artery [1–3]. In 20–75% of 
cases PVGI may lead to the death, while in 50% it may result in 
morbidity such as loss of a limb [1, 4]. Regarding the onset of PVGI, 
there are early and late infections. The early PVGI starts at the time 
of surgery, when causative organisms infect the graft and may 
appear up to 4 months after surgery, whereas the more common 
type — the late one, occurs at least 4 months after the implantation 
of prosthesis. In the early infections the clinical manifestations of 
PVGI can be acute, whereas in the late one, may be more subtle. 
The clinical presentation of the PVGI also depends on the location 
of the graft. In deeply fashioned grafts, pathology can be faint and 
difficult to diagnose. In cases of shallow grafts, for example in 
an extremity, the manifestations are often overt [4].
There are three groups of predisposing risk factor: patient- 
-related, procedure-related and pathogen-related. The patient-related 
aspects, among others, include: obesity, diabetes, immunode-
ficiency, infection at the time of graft placement, and prolonged
preoperative hospital stay [5, 6]. The procedure-related factors con-
nected with surgery are: prolonged, emergency or “redo” vascular 
surgery, bowel injury, groin incision, wound infections, postoperative
hematoma, seroma, pseudoaneurysm or wound-bed bleeding
[5–7]. The causative pathogens are Staphylococcus aureus and
Pseudomonas aeruginosa in 80% of cases, which produce a very
strong biofilm, and when they adhere to the graft, infections can
easily develop along the prosthesis and adjacent tissue. The patho-
gens also release destructive endotoxins, which can cause anasto-
motic dehiscence [6]. Synthetic vascular graft prostheses are made 
of either polyester (Dacron®) or polytetrafluoroethylene (PTFE),
both of which are also used in endovascular and open mode sur-
gery. The incidence of PVGI is comparable in both materials [7].
The right diagnosis of PVGI is crucial, but there is no clear 
consensus of diagnostics criteria. The imaging of PVGI is still 
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challenging, because false-positive tests may lead to unnecessary 
surgery, whereas false-negative are associated with under-treat-
ment and in consequence with high morbidity [4]. Routine tests in 
PVGI include: clinical, biochemical, microbiological and imaging 
studies. Laboratory analysis in prosthesis infection commonly reveal 
elevated white blood cell (WBC) count, increased C-reactive protein 
(CRP) serum level and increased sedimentation rate. Microbiologi-
cal assessment is based on skin, wound, blood or graft surrounding 
tissue culture. An ultrasound scan can easily detect peri-graft fluid. 
In contrast enhanced computed tomographic angiography (CECT), 
which is considered as the test of choice, the manifestation of infec-
tion is peri-graft ectopic gas, fluid and soft tissue enhancement and 
formation of the pseudoaneurysm. In advanced PVGI the detection 
rate in CECT is close 100%. Morphologic abnormalities are often 
nonspecific in vascular graft infection, therefore the use of metabolic 
study increases. The positron emission tomography/computed 
tomography (PET/CT) with use of 18F-fluoro-2-deoxy-D-glucose 
(18F-FDG) has become an important method of diagnosing in-
flammation and infection. In early and low-grade PVGI, the utility of 
18F-FDG PET/CT is increased. There are different grades of focal 
pattern of 18F-FDG uptake. 
In the recommendation of Management of Aortic Graft Infection 
Collaboration (MAGIC) there are three main categories of diagno-
sis of graft infection: clinical/surgical, radiological and laboratory 
[8]. Diagnostic criteria were ranked as either “major” or “minor” 
within each category. As it is recommended in MAGIC, Aortic 
Graft Infection (AGI) is suspected if one isolated major criterion 
or two of minor criteria from different categories are present. AGI 
is confirmed if there is one major plus any other criterion (major 
or minor) from another category. The major clinical/surgical cri-
teria include presence of pus, open wound, fistula development, 
graft insertion in infected site. The laboratory major criteria are 
pathogens recovered from explanted graft or intra-operative or 
from percutaneous aspirate of peri-graft fluid. The serum levels of 
inflammatory markers like erythrocyte sedimentation rate (ESR), 
CRP or WBC belong to the minor criteria in laboratory categories in 
MAGIC. Major radiological criteria on CT scan are peri-graft fluid 
more than 3 months or peri-graft gas more than 7 week after 
prosthesis insertion or increased peri-graft gas in serial imaging. 
Increased metabolic activity on 18F-FDG PET/CT belongs to 
minor radiological criteria of infections. In our opinion however, 
there is much more potential value in non-invasive examination 
like 18F-FDG PET/CT. There are a number of questions and 
concerns regarding the diagnosis of vascular prosthesis infec-
tions by 18F-FDG PET/CT, but the most important issue is finding 
the pattern of infection. 
The aim of the study was to identify the pattern of aortic vascular 
graft infection in patients with high probability of infective process by 
us of 18F-FDG PET/CT. 
Material and methods
Patients
The study was performed in 24 consecutive patients who 
attended Department of Nuclear Medicine University Hospital 
in Lublin, between March 2013 and October 2018, with vascular 
graft infection. Clinical material consisted of 21 male and 3 female 
patients, mean age 65 (35–84) years. Strong clinical suspicion 
of vascular graft infection was the start point of diagnosis. The 
definition of vascular prosthesis infection is graft colonization by 
pathological bacterial strains. According to mentioned above 
MAGIC criteria [8], the surgical manifestations were: fistula devel-
opment, infected pseudoaneurysm, erythema, warmth, swelling 
purulent discharge and pain. Than the laboratory tests, bacte-
rial culture and radiological signs of infection like: peri-graft air, 
persistent fluid or abscess was noticed in these patients. The 
main reason of vascular prosthesis implantation was aneurysm 
of the aorta (19 patients) and Leriche’s syndrome (5 patients). In 
general, there were 4 patients with a thoracic aorta graft (TAG) 
and 20 patients with an abdominal aorta graft (AAG). In 7 pa-
tients endovascular aortic repair (EVAR) was performed: in one 
patient in the thoracic aorta and in 6 patients in the abdominal 
aorta. In 17 patients an open surgery mode was applied. In 4 pa-
tients the femoro-popliteal graft coexisted (in patients with clas-
sical abdominal prostheses). 18F-FDG PET/CT were performed 
from 12 months to 15 years after vascular graft implantation with 
the exception of one patient, when 18F-FDG PET/CT was per-
formed 1 month after Bentall de Bono procedure, because of 
rapid progress of infection symptoms. There were 3 patients with 
diabetes mellitus in the group of stent-grafts patients. The blood 
serum inflammatory markers were: CRP mean 80.5 mg/L (range 
9–300) and WBC mean 13.4 (range 7–38) K/mL. Baseline study 
population is presented in Table 1.
18F-FDG PET/CT imaging
Patients were prepared for the study with 24 hours of low 
carbohydrate diet, and fast for at least 6 hours prior to the exami-
nation. The interval between insulin and 18F-FDG administration 
was more than 6 hours. Blood glucose level was measured just 
before injection and the mean value was 104.7 mg/dL, range 
was 78–140 mg/dL. One hour before imaging, the subjects were 
injected with 3.5 MBq of 18F-FDG per kilogram of body weight, 
mean activity 241.5 MBq, range 198–334 MBq. During the uptake 
phase, patients were waiting in a quiet, dimly lit room. Patients were 
scanned in supine position, with arms overhead. 18F-FDG PET/CT 
scans were obtained from the vertex of skull to the mid-thigh level 
using 18F-FDG PET/CT system Biograph mCT S(64)-4R (Siemens, 
Erlangen, Germany).
Table 1. Description of the study material
Patient’s details Localization of prosthesis
n Thoracic aortic graft Abdominal aortic 
graft
All 24 4 20
Age 24 48.8 years 60.3 years
Male 21 4 17
Female 3 0 3
EVAR 7 1 6




Diabetes mellitus 3 0 3
Smoking 17 3 14
EVAR — endovascular aortic repair
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PET data were collected in a three-dimensional mode, in the 
caudocranial direction with 2.5 minutes per bed position, and 
reconstructed with applied absorption and scatter correction. The 
reconstruction method was the following: True X+ time-of-flight 
(TOF) and ultra-high-resolution PET technology, 2 iterations, 21 sub-
sets, Gaussian filter full width at half maximum 2.0 mm, image size 
200 × 200 (matrix), zoom 1.0 and slice 3 mm. CT was performed 
prior to PET, without contrast enhancement, using the following 
parameters: voltage 120 kV, tube current 50, 150 or 200 mAs, pitch 
0.8, and slice thickness 3 mm.
Image analysis
All 18F-FDG PET/CT studies were independently assessed 
by a consensus of two experienced nuclear medicine physicians. 
Images were evaluated visually and semiquantitatively on a dedi-
cated workstation equipped with fusion software (Syngo Via VA30A, 
Siemens, Erlangen, Germany), which displays PET, CT, and PET/CT 
fused images. 
Vascular prostheses were evaluated visually, with two visual 
scales applied [9, 10]. The first one, a three-point scale, with 
18F-FDG uptake patterns scored as follows: 1. focal dominant area 
of 18F-FDG uptake; 2. inhomogeneous or patched and 3. diffused 
or homogenous [9]. According to published recommendation, the 
first two were recognized as PVGI [9]. Second visual scale was also 
utilized. It was a 5-point scale described by Sah et al. [10] where 
18F-FDG uptake patterns and CT information were taken into 
account. In this scale grade 1, 18F-FDG uptake in vascular graft 
was normal as in background activity; grade 2, mild increased but 
diffused along the graft; grade 3, focal, but mild uptake or strongly 
diffused; grade 4, focal and intense (and diffused 18F-FDG up-
take along the graft); grade 5, focal and intense 18F-FDG uptake 
plus fluid collections or abscess formation [10]. According to 
this scale, “mild” increase of 18F-FDG uptake means less than twice 
the blood pool activity in the ascending aorta, whereas “strong” 
means more than twice the blood pool activity in the ascending 
aorta. Similarly as described by Sah et al., in this work, in score 1 
and 2 images were considered as negative, whereas in score 3, 4 
and 5 as positive for graft infection.
Metabolic activity assessed by 18F-FDG uptake in of the vas-
cular graft was also evaluated by semi-quantitative analysis by use 
of maximum standardized uptake values (SUV max). The SUV max 
was calculated as the ratio of decay-corrected activity per cubic 
centimeter of tissue to the injected dosage divided by body weight.
For the semi-quantitative evaluation of the SUV max value, the 
region of interest (ROI) was placed in the focal area of the most 
intense 18F-FDG uptake. The background region, for background 
SUV max evaluation, was placed in the ascending aorta in case of 
abdominal prosthesis, and in abdominal aorta in case of thoracic 
one. 
There was also visual assessment of non-contrast enhanced 
CT performed during the 18F-FDG PET/CT examination. The CT 
findings in the vascular graft location were: gas bubbles, peri-graft 
fluid retention, thickening of the graft wall, adjacent blurred fat, soft 
tissue swelling, fistula and pseudoaneurysms.  
In the final diagnosis of PVGI the MAGIC criteria of clinical, 
radiological and laboratory tests were taken into account. 
Statistical analysis 
All calculations were expressed as mean ± standard deviation 
(SD), as well as minimal and maximal values. Differences between 
study groups were assessed with the U-Mann-Whitney test; p val-
ue < 0.05 was considered to indicate statistical significance. Data 
were evaluated using the statistical package Statistica, version 7. 
Ethics
The study was approved by the Bioethical Council, Medical 
University of Lublin, Poland. Informed consent was obtained from 
all participants. No side effects were observed after the radionu-
clide procedure.
Results
The analysis of vascular prostheses according to the both 
applied visual scales [9, 10] provided very similar results. In the 
3-point scale: 23 patients were in grade 1 and one patient was in 
grade 2. In the 5-point scale: 19 patients were in grade 5 with the 
highest activity in the focal area, 4 patients were in grade 4 and 
one patient in grade 3. The first two points in 3-point scale and 3 
last points in 5-point scale were recognized as PVGI. 
The visual assessment revealed that peri-graft high metabolic, 
focal activity was associated with occurrence of gas bubbles, 
peri-graft fluid retention, thickening of the graft wall, adjacent blurred 
fat, soft tissue swelling, fistula and pseudoaneurysm (Fig. 1). In 
3 cases (12.5%) increased focal 18F-FDG uptake in the infected 
grafts was found without morphological abnormalities (Fig. 2). The 
peri-graft fluid retention was observed in 16 patients, peri-graft 
gas in 15 patients, thickening around the graft wall, adjacent 
blurred fat and soft tissue swelling in 16 patients, fistula in 13 
patients, pseudoaneurysm in 15 patients and metabolically active 
lymph nodes in the area of PVGI in 10 patients. The triad of CT 
sign as pseudoaneurysms, soft tissue swelling and peri-graft fluid 
deposition were seen in 15 patients.  
The synthetic vascular graft prostheses were made of either 
polyester or PTFE, which are both used in endovascular and in 
open mode surgery. The highest metabolic activity, which was seen 
in the area of infection, was expressed by SUV max. In infected 
stent-grafts the metabolic activity came to SUV max 21.5, whereas in 
infected classical prosthesis was lower and came to SUV max 13. 
Only in one patient stent-graft was inserted in the thoracic aorta, 
and in 6 patients in the abdominal aorta. So because of the overall 
highest metabolic activity in the stent-graft generally, higher SUV 
max were observed in the abdominal prosthesis than in the thoracic 
one (21.5 vs.12.5). The metabolic activities expressed by SUVs in 
the infection area are presented in Table 2. 
There were statistically significant differences (p < 0.01) be-
tween mean SUV max in the infected area of stent-grafts compared 
to classical prostheses (SUV max 14.4 ± 5.1 vs 8.39 ± 2.56; 7 
vs 17 pts). This difference was less distinctive after background 
correction (p<0.02; SUV max 7.38 ± 4.07 vs 3.94 ± 1.31) (Tab. 3). 
The adjacent blurred fat and soft tissue swelling were combined 
with higher glucose metabolism compared to prostheses without 
these signs on CT scans (p < 0.005, SUV max 11.79 ± 4.08 
vs 6.84 ± 2.90, 16 vs 8 pts), with similar p value after background 
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Figure 1. Increased 18F-FDG uptake associated with irregular peri-graft soft tissue swelling and fluid retention around infected aortic stentgraft, 
demonstrated on coronal and sagittal projections of 18F-FDG PET/CT. Infection in the paraaortic lymph node with high radiopharmaceutical activity 
(arrow)
Figure 2. Focal 18F-FDG uptake (arrow) in infected classical prosthesis displayed on coronal and sagittal projections of 18F-FDG PET/CT
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correction (5.83 ± 3.12 vs 3.22 ± 1.39). The presence of the 
gas bubbles in adjacent tissue of prosthesis was linked to high up-
take of 18F- FDG (p < 0.01, SUV max 11.81 ± 4.35 vs 7.36 ± 2.80, 
15 vs 9 pts) as well as the peri-graft fluid retention, thickening of the 
peri-graft wall (p < 0.05, SUV max 5.61 ± 3.21 vs 3.62 ± 1.68, 16 
vs. 8 pts). Findings are presented in Table 4. Table 5 contains cor-
relation between visual grading scales and CT findings.
Microbiological findings were based on vascular graft, blood, 
wound, skin and fistula bacterial cultures. The culture were positive 
from prosthesis (Proteus mirabilis, Staphylococcus aureus, Entero-
coccus faecalis, Clostridium difficile), from fistula (Proteus mirabilis, 
Staphylococcus aureus, Klebsiella pneumonia, Escherichia coli), 
from blood (Escherichia coli, Enterobacter cloacae, Streptococ-
cus zooepidermicus), in one patient Candida albicans were de-
tected in urine. Some cultures were not conclusive (physiological 
skin culture or no bacterial growth). But in all patients, further clinical 
observation confirmed infections of PVG.  
In the follow-up of the studied group, 3 patients died in the 
course of infection: one patient with stent-graft of the ascending 
aorta in course of an esophageal fistula and two patients with 
aorto-bi-iliac stent-grafts. There was one patient who lost a lower 
limb. In 4 patients surgical treatment of infected vascular graft 
was not performed because of general bad condition and instability 
of the patients. In those patients antibiotic therapy was continued. In 
the rest of our patients surgical replacement of prosthesis was per-
formed. 
Discussion
Removal of the infected prosthesis, and replacement with 
another device to revascularization by anatomical or uninfected 
extra-anatomical route is an essential vascular graft infection 
treatment, beyond antibiotic therapy [11]. There is 18–30% 
mortality rate after surgical explantation of infected aortic pros-
thesis whereas leaving the prosthesis at the site of infection, 
despite prolonged antimicrobial treatment, results in 100% 
mortality over the course of 2 years [10, 12, 13]. The distinction 
Table 2. SUV max in the area of suspected of infection
Prosthesis n SUV max in area suspected of infection
median MAX MIN
All 24 9.0 21.5 4.2
EVAR 7 8.3 13.0 4.2
Open mode 17 14.4 21.5 4.8
Abdominal 20 9.3 12.5 4.8
Thoracic 4 10.2 21.5 4.2
EVAR — endovascular aortic repair
Table 3. Statistically significant differences between SUVs in the stent-grafts compared to classical prostheses
SUVmax Type of prosthesis Mean (SD) p
Without background correction Stent-grafts
classical prostheses
14.40 (SD = 5.01) n = 7 pts
8.39 (SD = 2.64) n = 17 pts
 
p < 0.01
With background correction Stent-grafts
classical prostheses
7.38 (SD = 4.07) n = 7 pts
3.94 (SD =1.30) n = 17 pts
 
p < 0.02
Table 4. Statistically significant differences between SUVs in the prosthesis with and without anatomic alterations on CT scans
SUVmax CT finding Mean (SD) p
Without background correction Gas bubbles yes 11.81 (SD = 4.35) n = 15 pts 
no 7.36 (SD = 2.80) n = 9 pts
 
p < 0.01
With background correction Gas bubbles yes 5.76 (SD = 3.23) n = 15 pts
no 3.58 (SD = 1.24) n = 9 pts
p < 0.01
With background correction Peri-graft fluid retention yes 5.61(SD = 3.21) n = 16 pts 
no 3.62 (SD = 1,68) n = 8 pts
 
p < 0.05
Without background correction Soft tissue swelling yes 11.79 (SD = 4.08) n = 16 pts 
no 6.84 (SD = 2.90) n = 8 pts
p < 0.005
With background correction Soft tissue swelling yes 5.80 (SD = 3.02) n = 16 pts 
no 3.23(SD = 1.39) n = 8 pts
 
p < 0.005











2 3 1 0 0 0 0 0 1 0
1
4 4 0 2 1 1 2 4 2
5 19 15 9 15 15 11 10 8
*Three-point scale 1) focal (one dominant area of uptake), 2) inhomogeneous or patched uptake, and 3) diffuse or homogenous uptake; **Five-point scale 1), normal background activity; 2), 
mildly increased, but diffuse FDG uptake along the graft (mild uptake: less than twice the blood pool activity in the ascending aorta; strong uptake: more than twice the blood pool activity in 
the ascending aorta); 3), focal, but only mild FDG uptake or strong diffuse FDG uptake along the graft; 4), focal and intense FDG uptake (± diffuse FDG uptake along the graft); 5), focal and 
intense FDG uptake plus fluid collections/abscess formation
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between infection and inflammation in reference to vascular pros-
thesis is very challenging, but absolutely crucial for the proper 
treatment. There are many various diagnostic schemes which 
include clinical, biochemical, microbiological and imaging proce-
dures [12]. As in the MAGIC recommendation, the clinical criteria 
of PVGI were the start point of diagnosis [8]. There were major 
criteria like fistula development and infected pseudoaneurysm 
as well as minor criteria like erythema, warmth, swelling purulent 
discharge and pain. They occurred in all patients in various de-
grees. The serum levels of CRP and WBC belonging to the minor 
criteria in laboratory categories in MAGIC were increased in the 
studied patients. The golden standard in the diagnosis of PVGI 
is confirmation of bacterial colonization of prosthesis. In MAGIC 
criteria organisms recovered from explanted graft or recovered 
from intra-operative or radiologically guided aspiration of peri-graft 
belong to the major criteria of infections. Positive blood culture 
with no apparent source of infection except of AGI, are the minor 
criteria of infections [8]. Staphylococcus species are the most 
common causative organisms, Staphylococcus aureus are more 
likely in early infection and Staphylococcus epidermidis in late 
infections [13]. However, many suspected PVGI are treated with-
out knowing the causative organisms, because as described by 
FitzGerald et al. suitable specimens could not be obtained or 
antibiotic treatment was applied before collection of samples [13]. 
Some authors stress that even if the specimens are taken from 
blood or from the suspicious location, there could be negative 
bacterial culture in active vascular prosthesis infections [14]. On 
the other hand, same pathogens isolated from superficial speci-
mens may be misleading, but influence the choice of antimicrobial 
agents [13]. For this reason, antimicrobial treatment is empirical 
and based on clinical manifestations and findings, as well as on 
radiological/nuclear medical imaging.  
Contrast-enhanced computed tomography has close to 100% 
sensitivity and specificity in diagnosis of acute PVGI, whereas in 
chronic PVGI up to 55% [15]. Presentation of periprosthesis air bub-
bles, abscesses or infiltration suggests vascular graft infections in 
CT. Nevertheless, it should be kept in mind that one week after 
vascular prosthesis implantation, air bubbles are present around 
the vascular prosthesis in 65% of patients [16]. Moreover, in 100% 
of patients periprosthetic hematoma is present in CT one week 
after surgery and in 10% of patients at 100 days post-surgery [17]. 
However, in all patients presenting air bubbles, periprosthetic infil-
tration or fluid collections 3 months post-surgery, the possibility of 
a vascular graft infection should be taken into account [13].  
In nuclear medicine procedures there are two main techniques, 
SPECT and PET, and several radiopharmaceuticals like Gallium 
67-citrate, radiolabeled white blood cells, antigranulocyte antibody. 
In the PET technique there is the main radiotracer 18F-FDG. Ac-
cording to the EANM/SNMMI guidelines [18], the advantage of 
use of 18F-FDG PET/CT over radiolabeled WBC scintigraphy in 
detection of infection in vascular prosthesis is unclear. However, 
the usage of 18F-FDG PET/CT is less time-consuming and much 
easier to perform compared to radiolabeled WBC scintigraphy. The 
reported sensitivity, specificity and accuracy of scintigraphy with 
radiolabeled WBC in PVGI is 100%, 92%, 97% respectively [19], 
whereas the latest study of 18F-FDG PET/CT presents sensitivity, 
specificity, positive and negative predictive value 88%, 79%, 67%, 
and 93% respectively [9]. 
18F-FDG PET/CT provides information regarding not 
only of the  anatomy  but also the  metabolism  of lesions. Three 
cases (12.5%) in the studied population presented increased 
18F-FDG uptake in the infected grafts without morphological ab-
normalities on CT scans. In some patients 18F-FDG PET/CT also 
revealed extra-prosthetic infection in the lymph nodes. Therefore, 
an additional value of PET/CT over CT alone was documented in 
this study. Recently the combination of PET/CT with contrast en-
hanced CT is postulated in diagnosing PVGI as it was proved to be 
more accurate than stand-alone imaging and may be supportive 
in future management of difficult cases [20]. 
In the studied patients there were two types of vascular graft 
prosthesis: stent-grafts (EVAR procedure) and classic prostheses. 
All prostheses were made of either polyester or [7], which are 
both use in endovascular and open surgery. Synthetic vascular 
grafts provoke a chronic low-grade inflammation, therefore could 
be a cause of a false positive diagnosis [21]. Our material revealed 
higher metabolic activity in stent-grafts than classical prosthesis, 
but further studies are needed because of potentially higher arti-
facts from metallic elements contained in the stent-grafts. On the 
other hand, the number of patients in both groups was not very high.
Testing a short time after implantation could be a source of 
a false positive finding [22]. The mean time between the surgery and 
18F-FDG PET/CT in the studied group of patients was 51 months, 
but in one patient imaging was performed 1 month after Bentall de 
Bono procedure, because of rapid progress of infection symptoms. 
This patient died over the course of the infection. However, gener-
ally in cases of very early assessment of vascular prosthesis, the 
diagnosis should be made very carefully. In the early period after 
implantation there are post-surgical inflammatory changes in the 
area of implantation, with physiological activation of leukocytes. 
Peri-graft fluid and peri-graft gas observed in CT integrated with 
PET meet the major criteria of aortic graft infection enclosed in 
MAGIC criteria [8]. They depend on the time after surgery, so 
persistent peri-graft fluid after more than 3 months and peri-graft 
gas after more than 7 weeks after insertion, suggest PVGI. In our 
analysis, except one patient, the time criteria have been met. In 
this study peri-graft fluid was observed in 16 and peri-graft gas in 
15 patients. Presence of pseudoaneurysm and fistula are the minor 
criteria of MAGIC and in our study were observed in 15 and in 13 
patients respectively.
Pattern of 18F-FDG uptake in patients with suspicion of vas-
cular graft infection is very important. Focal or heterogeneous ac-
cumulation is highly suggestive of infection  whereas moderate, 
homogeneous, linear uptake in the graft and/or surrounding tissue 
is often recognized as non-infectious [22, 23]. However, some 
authors underline that patterns of FDG uptake for uninfected 
grafts largely overlap with those of infected vascular graft [24]. 
In these cases it is very important to recognize all the additional 
signs of potential infection. Concerning the 18F-FDG uptake and 
distribution patterns, reported sensitivity, specificity, positive predic-
tive value and negative predictive value in PVGI are 93%, 91%, 88%, 
96% respectively [25]. In this study of analysis of 18F-FDG uptake 
in prosthesis and in the surrounding tissues two visual scales were 
applied [9, 10]. Both of them presented very similar results, FDG 
uptake was focal (mild to intense) in all patients. 18F-FDG PET/CT 
as hybrid study additionally revealed in our patients signs of infec-
tions in CT, like: gas bubbles, peri-graft fluid retention, thickening of 
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the graft wall, adjacent blurred fat, soft tissue swelling, fistula and 
pseudoaneurysm. All the patients in the study were positive in refer-
ence to infection. Moreover, in MAGIC criteria increased peri-graft 
18F-FDG activity fulfills the minor criteria of aortic graft infection [8]. 
On the other hand, based only on assessment of 18F-FDG 
uptake it is very difficult to differentiate a quite rare condition like 
retroperitoneal fibrosis (RPF), which could be also secondary to 
vascular graft implantation from a simple inflammatory reaction 
to a foreign body or the early phase of an infection. In all these 
conditions there is increased 18F-FDG uptake and serum level of 
inflammatory markers, as well as clinical symptoms like fever and 
pain. In RPF treatment is based on glucocorticosteroids applica-
tion, in inflammation as foreign body reaction – watchful waiting 
is much advisable, whereas in the last case redo surgery is usually 
performed. Therefore, it should be kept in mind, that diagnosis of 
PVGI should be based on multidisciplinary consensus [26].  
Conclusions
18F-FDG PET/CT is a very useful, non-invasive tool for assess-
ment of vascular graft infections. It should be interpreted with cau-
tion in multidisciplinary teem. CT findings like gas bubbles, peri-graft 
fluid retention, thickening of the graft wall and adjacent blurred fat 
soft tissue swelling are associated with significantly higher glucose 
metabolism: however, in some cases without anatomic alterations, 
increased metabolic activity is the only sign of infection. A use-
ful marker of infected graft is focal not homogeneous pattern of 
18F-FDG uptake found in all examined cases.
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